|
⚲
|
| Keyboard |
| Alan Ezrin | |
|---|---|
| Firm | |
| Address | 4350 Brownsboro Road Suite 110 Louisville, KY 40207 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| NX Pharmagen Inc | 021-462445 | Director | 0.6 M of 1.0 M |
||
| Nexosome Oncology Holdings Inc | 021-422096 | Director | 3.7 M of 4.0 M |
||
| NX Pharmagen Inc | 021-374530 | Director | 0.5 M of 1.0 M |
||
| Bradmer Pharmaceuticals Inc | 021-306793 | Executive Officer | 38.5 M of 38.5 M |
||
| NX Development Corp | 021-264008 | Executive Officer | 0.7 M of 2.9 M |
||
| NX Development Corp | 021-235804 | Executive Officer | 1.8 M of 2.0 M |
||
| NX Pharmagen Inc | 021-198568 | Executive Officer | 0.8 M of 1.0 M |
||
| NX Pharmagen Inc | 021-152561 | Executive Officer | of 1.5 M |
||